Pasteur Network

The Pasteur Network is an international association of approximately 33 research and public health institutes in 25 countries, connected by a shared scientific heritage and formal affiliation to the Institut Pasteur in Paris. Member institutes span West Africa (Institut Pasteur de Dakar), Southeast Asia, the Caribbean, Latin America, and the Pacific. Each member operates independently with its own funding and governance, but the network provides shared scientific standards, training pathways, biosafety infrastructure, and inter-lab sequencing and diagnostic protocols. The Pasteur Network is a first-line laboratory resource for outbreak response in many of the regions where it operates, combining national-authority legitimacy with international scientific standards.

CEPI expanded its partnership with the Pasteur Network on 21 April 2026 to build regional vaccine R&D capacity across West Africa, Southeast Asia, and the Caribbean as part of the Moderna H5N1 Phase 3 infrastructure. The expansion adds Pasteur Network laboratory capacity to the H5N1 surveillance footprint, relevant because member institutes including Institut Pasteur de Dakar are conducting serology, sequencing and metagenomic analysis on MV Hondius cluster samples alongside NICD South Africa. The Pasteur Network's geographic footprint in endemic-disease regions gives the CEPI arrangement practical value beyond the trial itself: network labs can generate pathogen-surveillance data that feeds into the next round of WHO R&D Blueprint priority pathogen decisions.